{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:32:29Z","timestamp":1752229949572,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:00:00Z","timestamp":1637971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:00:00Z","timestamp":1637971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010688","name":"instituto nacional de ci\u00eancia e tecnologia da criosfera","doi-asserted-by":"publisher","award":["303752\/2015-7"],"award-info":[{"award-number":["303752\/2015-7"]}],"id":[{"id":"10.13039\/501100010688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"funda\u00e7\u00e3o de amparo \u00e0 pesquisa do estado de s\u00e3o paulo","doi-asserted-by":"publisher","award":["2011\/02779-1"],"award-info":[{"award-number":["2011\/02779-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The reactivation rate of tuberculosis in patients with chronic inflammatory arthritis (CIA) on TNF\u03b1 inhibitors (TNFi) and baseline negative screening for latent tuberculosis infection (LTBI) is higher than in the general population.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>To compare the performance of tuberculin skin test (TST), TST-Booster, ELISPOT (T-SPOT.TB) and QuantiFERON-TB Gold in tube (QFT-IT) to detect LTBI in patients with CIA on TNFi.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients and methods<\/jats:title>\n                <jats:p>A total of 102 patients with CIA [rheumatoid arthritis (RA), n\u2009=\u200940; ankylosing spondylitis (AS), n\u2009=\u200935; psoriatic arthritis (PsA), n\u2009=\u20097; and juvenile idiopathic arthritis (JIA), n\u2009=\u200920] were prospectively followed-up for 24\u00a0months to identify incident LTBI cases. Epidemiologic data, TST, T-SPOT.TB, QFT-IT and a chest X-ray were performed at baseline and after 6\u00a0months of LTBI treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty six percent (37\/102) of patients had positive TST or Interferon Gamma Release Assays (IGRAs) tests. Agreement among TST and IGRAs was moderate (k\u2009=\u20090.475; <jats:italic>p<\/jats:italic>\u2009=\u20090.001), but high between T-SPOT.TB and QFT-IT (k\u2009=\u20090.785; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). During the 24-Month follow-up, 15 (18.5%) incident cases of LTBI were identified. In comparison to TST, the IGRAs increased the LTBI diagnosis power in 8.5% (95% CI 3.16\u201317.49). TST-Booster did not add any value in patients with negative TST at baseline. After 6-Month isoniazid therapy, IGRAs results did not change significantly.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Almost 20% of CIA patients had some evidence of LTBI, suggesting higher conversion rate after exposition to TNFi. TST was effective in identifying new cases of LTBI, but IGRAs added diagnostic power in this scenario. Our findings did not support the repetition of IGRAs after 6-Month isoniazid therapy and this approach was effective to mitigate active TB in 2\u00a0years of follow-up.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42358-021-00226-z","type":"journal-article","created":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T08:02:53Z","timestamp":1638000173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Performance of 4 methods for screening of latent tuberculosis infection in patients with chronic inflammatory arthritis under TNF\u03b1 inhibitors: a 24-month prospective study"],"prefix":"10.1186","volume":"61","author":[{"given":"Carina M. F.","family":"Gomes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Terreri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Isabel","family":"Moraes-Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7901-3124","authenticated-orcid":false,"given":"Marcelo M.","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,27]]},"reference":[{"key":"226_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnet","year":"1988","unstructured":"Arnet FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum"},{"key":"226_CR2","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665\u201373.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"226_CR3","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, et al. The assessment of spondyloarthritis international society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68(Suppl 2):ii1-44.","journal-title":"Ann Rheum Dis"},{"key":"226_CR4","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"226_CR5","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1086\/383317","volume":"38","author":"RS Wallis","year":"2004","unstructured":"Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis. 2004;38:1261\u20135.","journal-title":"Clin Infect Dis"},{"key":"226_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1086\/506935","volume":"43","author":"P Brassard","year":"2006","unstructured":"Brassard P, Kezouh A, Suissa S. Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis. 2006;43:717\u201322.","journal-title":"Clin Infect Dis"},{"key":"226_CR7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1590\/0074-02760150235","volume":"110","author":"CM Gomes","year":"2015","unstructured":"Gomes CM, Terreri MT, Moraes-Pinto MI, Barbosa C, Machado NP, Melo MR, et al. Incidence of active mycobacterial infections in Brazilian patients with chronic inflammatory arthritis and negative evaluation for latent tuberculosis infection at baseline\u2014a longitudinal analysis after using TNF\u0251 blockers. Mem Inst Oswaldo Cruz. 2015;110:921\u20138.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"226_CR8","doi-asserted-by":"publisher","first-page":"905","DOI":"10.5588\/ijtld.13.0755","volume":"18","author":"KR Bonfiglioli","year":"2014","unstructured":"Bonfiglioli KR, Ribeiro AC, Moraes JC, Saad CG, Souza FH, Calich AL, et al. LTBI screening in rheumatoid arthritis patients prior to anti-TNF treatment in an endemic area. Int J Tuberc Lung Dis. 2014;18:905\u201311.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"RR-5","key":"226_CR9","first-page":"1","volume":"59","author":"GH Mazurek","year":"2010","unstructured":"Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2010;59(RR-5):1\u201325.","journal-title":"MMWR Recomm Rep"},{"key":"226_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/art.1780380106","volume":"38","author":"JS Smolen","year":"1995","unstructured":"Smolen JS, Breedveld FC, Eberl G, Jones I, Leeming M, Wylie GL, et al. Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum. 1995;38:38\u201343.","journal-title":"Arthritis Rheum"},{"key":"226_CR11","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol. 1994;21:2286\u201391.","journal-title":"J Rheumatol"},{"key":"226_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000250839","volume":"157","author":"T Fredriksson","year":"1978","unstructured":"Fredriksson T, Pettersson U. Severe psoriasis\u2014oral therapy with a new retinoid. Dermatologica. 1978;157:238\u201344.","journal-title":"Dermatologica"},{"key":"226_CR13","first-page":"2290","volume":"31","author":"CA Wallace","year":"2004","unstructured":"Wallace CA, Ruperto N, Giannini E, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology International Trials Organization, Pediatric Rheumatology Collaborative Study Group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31:2290\u20134.","journal-title":"J Rheumatol"},{"key":"226_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10067-008-1007-9","volume":"28","author":"I Fuchs","year":"2009","unstructured":"Fuchs I, Avnon L, Freud T, Abu-Shakra M. Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors. Clin Rheumatol. 2009;28:167\u201372.","journal-title":"Clin Rheumatol"},{"key":"226_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1183\/09031936.00115110","volume":"37","author":"R Diel","year":"2011","unstructured":"Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, et al. Interferon-\u03b3 release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011;37:88\u201399.","journal-title":"Eur Respir J"},{"key":"226_CR16","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1086\/597351","volume":"48","author":"MC Aichelburg","year":"2009","unstructured":"Aichelburg MC, Rieger A, Breitenecker F, Pfistershammer K, Tittes J, Eltz S, et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis. 2009;48:954\u201362.","journal-title":"Clin Infect Dis"},{"key":"226_CR17","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1128\/JCM.02411-05","volume":"44","author":"SJ Tsiouris","year":"2006","unstructured":"Tsiouris SJ, Coetzee D, Toro PL, Austin J, Stein Z, El-Sadr W. Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol. 2006;44:2844\u201350.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"226_CR18","doi-asserted-by":"publisher","first-page":"e2489","DOI":"10.1371\/journal.pone.0002489","volume":"3","author":"E Raby","year":"2008","unstructured":"Raby E, Moyo M, Devendra A, Pfistershammer K, Tittes J, Eltz S, et al. The effects of HIV on the sensitivity of a whole blood interferon gamma release assay in Zambian adults with active tuberculosis. PLoS ONE. 2008;3(6):e2489.","journal-title":"PLoS ONE"},{"key":"226_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1590\/S0482-50042011000100004","volume":"51","author":"MR Callado","year":"2011","unstructured":"Callado MR, Lima JR, Nobre CA. Vieira WP [Low prevalence of reactive PPD prior to infliximab use: comparative study on a population sample of Hospital Geral de Fortaleza]. Rev Bras Reumatol. 2011;51:40\u201352.","journal-title":"Rev Bras Reumatol"},{"key":"226_CR20","first-page":"121","volume":"42","author":"CDL Marques","year":"2009","unstructured":"Marques CDL, Duarte ALBP, Lorena VMB, de Souza JR, Souza W, Gomes YM, et al. Atenuate response to tuberculin skin test in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis. Rev Bras Reumatol. 2009;42:121\u201331.","journal-title":"Rev Bras Reumatol"},{"key":"226_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/annrheumdis-2014-205376","volume":"74","author":"C Hatzara","year":"2015","unstructured":"Hatzara C, Hadziynnis E, Kandili A, Tsikrika S, Minopetrou M, Georgiopoulos G, et al. Frequent conversion of tuberculosis screening tests during anti-tumor necrosis fator therapy in patients with rheumatic diseases. Ann Rheum Dis. 2015;74:1\u20136.","journal-title":"Ann Rheum Dis"},{"key":"226_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/acr.21641","volume":"64","author":"JA Singh","year":"2012","unstructured":"Singh JA, Furst DE, Bharat A, Curtis J, Kavanaugh A, Kremer J, et al. 2012 Update of the 2008 American College of Rheumatology (ACR) recommendations for the use of disease-modifying anti-rheumatic drugs and biologics in the treatment of rheumatoid arthritis (RA). Arthritis Care Res. 2012;64:625\u201339.","journal-title":"Arthritis Care Res"},{"key":"226_CR23","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1378\/chest.13-1232","volume":"145","author":"JL Johnson","year":"2014","unstructured":"Johnson JL, Geldenhuys H, Thiel BA, Toefy A, Suliman S, Pienaar B, et al. Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study. Chest. 2014;145:612\u20137.","journal-title":"Chest"},{"key":"226_CR24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1017\/S0950268815001727","volume":"144","author":"MA Ferrarini","year":"2016","unstructured":"Ferrarini MA, Spina FG, Weckx LY, Lederman HM, De Moraes-Pinto MI. Rate of tuberculosis infection in children and adolescents with household contact with adults with active pulmonary tuberculosis as assessed by tuberculin skin test and interferon-gamma release assays. Epidemiol Infect. 2016;144:712\u201323.","journal-title":"Epidemiol Infect"},{"key":"226_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1164\/rccm.201208-1352OC","volume":"187","author":"IM Adetifa","year":"2013","unstructured":"Adetifa IM, Ota MO, Jeffries DJ, Lugos MD, Hammond AS, Battersby NJ, et al. Interferon \u03b3 ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial. Am J Respir Crit Care Med. 2013;187:439\u201345.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-021-00226-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-021-00226-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-021-00226-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T20:08:48Z","timestamp":1638043728000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-021-00226-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,27]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["226"],"URL":"https:\/\/doi.org\/10.1186\/s42358-021-00226-z","relation":{},"ISSN":["2523-3106"],"issn-type":[{"type":"electronic","value":"2523-3106"}],"subject":[],"published":{"date-parts":[[2021,11,27]]},"assertion":[{"value":"15 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Research. Subjects were included in the study after signing an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients gave consent for anonymous data publication, in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no disclosures or any conflict of interest for this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}